Respules:
Our advanced Respules offer precise and convenient delivery of medication for respiratory conditions. These single-use units contain nebulized medication, ensuring accurate dosage and efficient administration.
DPIs provide a user-friendly and portable solution for respiratory therapy. They deliver dry powder medication directly to the lungs, offering quick relief and effective management of respiratory conditions.
Our MDIs are widely used for the treatment of asthma and other respiratory disorders. They deliver measured doses of medication, making them easy to use and suitable for both adults and children.
Our nasal sprays offer targeted relief for sinus congestion, allergies, and other nasal conditions. They provide rapid and precise delivery of medication to the nasal passages.
Tablets:
Our respiratory tablets are formulated to provide sustained and effective relief for various respiratory ailments. With accurate dosing and easy administration, they ensure patient compliance and satisfaction.
Softgel Capsules:
Our softgel capsules are designed to deliver medication in a convenient and easy-to-swallow format. They are an excellent option for patients who have difficulty taking tablets or prefer a softgel formulation.
Hard gel Capsules:
Our hard gel capsules offer a stable and reliable way to deliver respiratory medication. They are tamper-proof and preserve the potency of the enclosed drug.
Syrups:
Our respiratory syrups are available in various flavors and strengths, providing an easy-to-administer option for patients, especially children. They offer effective relief from cough, cold, and other respiratory symptoms.
PCD Pharma Franchise Monopoly Basis- Why Choose One Air International?
Compliance and Certifications
Our company is committed to maintaining compliance with all regulatory requirements and industry standards. We hold various certifications that testify to our commitment to quality and adherence to best practices.
Product Range at One Air International
| PRODUCT | COMPOSITION |
| BUDEWIDE L | Budesonide 0.5Mg & Levosalbutamol 1.25mg |
| BUDEWIDE F | Budesonide 0.5Mg & Formoterol 20mcg |
| DUOJUMP | Levosalbutamol 1.25mg & Ipratropium Bromide 500mcg |
| FLUTIZING S | Fluticasone Propionate 250mcg & Salmeterol Xinafoate 50mcg |
| HARROSE DSR | Rabeprazole 20 Mg & Domperidone 30 Mg SR |
| EVERYDAY DSR | Pantoprazole 40 Mg & Domperidone 30 Mg SR |
| ONEKOFF DX | Chlorpheniramine Maleate 2mg + Dextromethorphan Hydrobromide10mg + Phenylephrine hydrochloride 5mg |
PCD Pharma Franchise Monopoly Basis- Benefits of Partnering with Us
Exclusive Territory:
When you choose our monopoly pharma franchise, you gain exclusive rights to market our respiratory products in your designated territory. This exclusivity provides a competitive edge in the market and allows you to build a loyal customer base.
Wide Product Range:
With our extensive range of respiratory products, you can cater to the diverse needs of patients in your region. From inhalers for chronic conditions to syrups for acute respiratory symptoms, our products cover a wide spectrum of respiratory care.
Quality Assurance:
As a reputable pharmaceutical company, we prioritize product quality and efficacy. Our strict quality control measures ensure that each product meets international standards, providing you and your customers with peace of mind.
Marketing and Promotional Support:
We understand that effective marketing is crucial for success in the pharmaceutical industry. As our franchise partner, you will receive comprehensive marketing and promotional support to boost your brand visibility and reach a wider audience.
Training and Product Knowledge:
We believe that knowledge is key to success. As part of our franchise program, we provide thorough training on our products and their usage, ensuring that you and your team are well-equipped to provide accurate information to healthcare professionals and patients.
Why Respiratory Products are in High Demand?
The demand for respiratory products has been steadily increasing, primarily due to the rising prevalence of respiratory disorders worldwide. Factors such as air pollution, allergens, and lifestyle changes have contributed to a surge in respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis.
Moreover, the ongoing COVID-19 pandemic has further underscored the importance of respiratory health. Respiratory products such as metered dose inhalers and nasal sprays have played a critical role in managing COVID-19 symptoms and reducing the severity of respiratory distress in affected patients.
How to Select the Right Pharma Franchise Partner For PCD Pharma Franchise Monopoly Basis?
Choosing the right pharmaceutical company for is crucial for your business success.
Here are some key factors to consider when selecting a partner:
Product Range:
Ensure that the company offers a comprehensive range of respiratory products to meet the diverse needs of patients in your territory.
Quality and Compliance:
Check the company’s adherence to strict quality control measures and compliance with regulatory standards to ensure the safety and efficacy of their products.
Marketing and Promotional Support:
Evaluate the level of marketing and promotional support provided by the company to boost your brand presence and visibility in the market.
Training and Support:
Look for a partner that offers comprehensive training and ongoing support to equip you and your team with product knowledge and sales skills.
Experience and Reputation:
Choose a company with a proven track record and a positive reputation in the pharmaceutical industry.
One Air International is dedicated to providing high-quality respiratory products and offering lucrative opportunities. With a commitment to quality, marketing support, and a wide product range, we are the ideal partner for entrepreneurs looking to establish a successful and rewarding pharmaceutical business. Join us and make a significant impact on respiratory health while achieving business success. Contact us today to explore our PCD pharma franchise monopoly basis opportunities.
